These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25257311)

  • 41. Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2.
    Zhang S; Chen Q; Liu Q; Li Y; Sun X; Hong L; Ji S; Liu C; Geng J; Zhang W; Lu Z; Yin ZY; Zeng Y; Lin KH; Wu Q; Li Q; Nakayama K; Nakayama KI; Deng X; Johnson RL; Zhu L; Gao D; Chen L; Zhou D
    Cancer Cell; 2017 May; 31(5):669-684.e7. PubMed ID: 28486106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients' Survival.
    Godlewski J; Kiezun J; Krazinski BE; Kozielec Z; Wierzbicki PM; Kmiec Z
    Biomed Res Int; 2018; 2018():2653623. PubMed ID: 29850494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancer.
    Jeong W; Kim SB; Sohn BH; Park YY; Park ES; Kim SC; Kim SS; Johnson RL; Birrer M; Bowtell DSL; Mills GB; Sood A; Lee JS
    Anticancer Res; 2014 Feb; 34(2):811-817. PubMed ID: 24511017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.
    Nishio M; Sugimachi K; Goto H; Wang J; Morikawa T; Miyachi Y; Takano Y; Hikasa H; Itoh T; Suzuki SO; Kurihara H; Aishima S; Leask A; Sasaki T; Nakano T; Nishina H; Nishikawa Y; Sekido Y; Nakao K; Shin-Ya K; Mimori K; Suzuki A
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E71-80. PubMed ID: 26699479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways.
    Santinon G; Pocaterra A; Dupont S
    Trends Cell Biol; 2016 Apr; 26(4):289-299. PubMed ID: 26750334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
    Marshall M
    Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
    Chai J; Xu S; Guo F
    Biochem Biophys Res Commun; 2017 Jun; 488(2):297-302. PubMed ID: 28483529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Energy crisis and the Hippo pathway.
    Wang W; Li X; Chen J
    Cell Cycle; 2015; 14(13):1995-6. PubMed ID: 25942485
    [No Abstract]   [Full Text] [Related]  

  • 49. ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells.
    Machado-Neto JA; Lazarini M; Favaro P; Franchi GC; Nowill AE; Saad ST; Traina F
    Exp Cell Res; 2014 Jun; 324(2):137-45. PubMed ID: 24726915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells.
    Kim JW; Berrios C; Kim M; Schade AE; Adelmant G; Yeerna H; Damato E; Iniguez AB; Florens L; Washburn MP; Stegmaier K; Gray NS; Tamayo P; Gjoerup O; Marto JA; DeCaprio J; Hahn WC
    Elife; 2020 Jan; 9():. PubMed ID: 31913126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature.
    Poma AM; Torregrossa L; Bruno R; Basolo F; Fontanini G
    Sci Rep; 2018 Jul; 8(1):10623. PubMed ID: 30006603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The kelch proteins Gpb1 and Gpb2 inhibit Ras activity via association with the yeast RasGAP neurofibromin homologs Ira1 and Ira2.
    Harashima T; Anderson S; Yates JR; Heitman J
    Mol Cell; 2006 Jun; 22(6):819-830. PubMed ID: 16793550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assembly and activation of the Hippo signalome by FAT1 tumor suppressor.
    Martin D; Degese MS; Vitale-Cross L; Iglesias-Bartolome R; Valera JLC; Wang Z; Feng X; Yeerna H; Vadmal V; Moroishi T; Thorne RF; Zaida M; Siegele B; Cheong SC; Molinolo AA; Samuels Y; Tamayo P; Guan KL; Lippman SM; Lyons JG; Gutkind JS
    Nat Commun; 2018 Jul; 9(1):2372. PubMed ID: 29985391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer.
    Latz S; Umbach T; Goltz D; Kristiansen G; Müller SC; Ellinger J
    Urol Int; 2016; 96(1):39-45. PubMed ID: 26287745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival.
    Menzel M; Meckbach D; Weide B; Toussaint NC; Schilbach K; Noor S; Eigentler T; Ikenberg K; Busch C; Quintanilla-Martinez L; Kohlhofer U; Göke A; Göke F; Handgretinger R; Ottmann C; Bastian BC; Garbe C; Röcken M; Perner S; Kohlbacher O; Bauer J
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):671-3. PubMed ID: 24703331
    [No Abstract]   [Full Text] [Related]  

  • 56. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
    Qian F; Xiao J; Gai L; Zhu J
    Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1.
    Islam SS; Uddin M; Noman ASM; Akter H; Dity NJ; Basiruzzman M; Uddin F; Ahsan J; Annoor S; Alaiya AA; Al-Alwan M; Yeger H; Farhat WA
    EBioMedicine; 2019 May; 43():211-224. PubMed ID: 31085100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Normal hematopoietic stem cell function in mice with enforced expression of the Hippo signaling effector YAP1.
    Jansson L; Larsson J
    PLoS One; 2012; 7(2):e32013. PubMed ID: 22363786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.
    Shanzer M; Ricardo-Lax I; Keshet R; Reuven N; Shaul Y
    Oncogene; 2015 Aug; 34(32):4190-8. PubMed ID: 25362852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A feed forward loop enforces YAP/TAZ signaling during tumorigenesis.
    Gill MK; Christova T; Zhang YY; Gregorieff A; Zhang L; Narimatsu M; Song S; Xiong S; Couzens AL; Tong J; Krieger JR; Moran MF; Zlotta AR; van der Kwast TH; Gingras AC; Sicheri F; Wrana JL; Attisano L
    Nat Commun; 2018 Aug; 9(1):3510. PubMed ID: 30158528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.